Nathan Wolfensberger
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Late toxicity of allogeneic stem cell transplantation for Non-Hodgkin lymphoma patients. SBST based analysis 1997-2021 and review of literature.
Journal: Transplantation and cellular therapy
Published: August 08, 2025
Early Free Light-Chain Suppression as a Prognostic Marker in Relapsed and Refractory Myeloma Patients Treated With BCMA-Directed CAR-T Cells.
Journal: EJHaem
Published: July 16, 2025
Prophylactic Tocilizumab prior to infusion of CD19 CAR T-cells reduces therapy-related complications in older lymphoma patients.
Journal: Annals of hematology
Published: March 17, 2025
Inferior Overall Survival After Haploidentical Donor Lymphocyte Infusions in Relapsed Myeloid Neoplasms.
Journal: European journal of haematology
Published: July 18, 2024
B-cell maturation antigen-directed bispecific antibodies in plasmablastic lymphoma.
Journal: British journal of haematology
Published: April 03, 2024
Antibody response to a third SARS-CoV-2 vaccine dose in recipients of an allogeneic haematopoietic cell transplantation.
Journal: British journal of haematology
Published: September 11, 2022
Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: November 26, 2021
Rapid Centrifugation in the Routine Hemostasis Laboratory.
Journal: Thrombosis and haemostasis
Published: October 11, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026